Todas las investigaciones
ReclutamientoUso terapéutico (Fase IV)Intervencionista

GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre pragmatic randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission.

The GO TEST FINALE study aims to find the best long-term treatment strategy for people whose gout is currently well-controlled. If your gout is in remission (meaning you haven't had recent flare-ups), doctors are trying to understand if you should continue taking your existing gout medicines, like allopurinol, benzbromarone, or febuxostat, or if it's safe and beneficial to stop them. This study will follow participants for 24 months, observing how many remain free from gout flare-ups over the last six months of the study. It's a large study involving many different clinics, designed to give clear answers to this important question for gout patients in the UK.

De un vistazo

Estado
Reclutamiento
Fase
Uso terapéutico (Fase IV)
Patrocinador
Sint Maartenskliniek
Objetivo de inscripción
310
Inicio
09 Jul 2024

¿De qué trata este estudio?

The GO TEST FINALE study is a very important research project looking into the best way to manage gout for the long term. Many people take medication to keep their gout under control, and when it's settled and they're not having flare-ups, it's called being in 'remission'. This study wants to find out what happens if these people either continue taking their gout medication or if they stop taking it.

The main goal is to see if continuing your medication, even when you feel well, is better than stopping it. Researchers will be comparing different common gout medicines, such as allopurinol, benzbromarone, and febuxostat. This research is a 'Phase IV' study, which means these are already approved medications and doctors are studying the best way to use them in real-world situations, rather than testing completely new drugs.

The results of this study could help doctors make clearer recommendations about how long people should take their gout medication after their condition has settled. This could make a big difference to how gout is managed for many people across the UK, potentially reducing the need for unnecessary medication or preventing future flare-ups.

Puntos clave

  • The study explores if people with well-controlled gout can safely stop their medication.
  • It lasts for two years and compares continuing vs. stopping standard gout medicines.
  • Participation involves regular check-ups to monitor your gout.
  • It aims to provide important answers for long-term gout management.
  • Puede retirarse del estudio en cualquier momento.

¿Quién puede ser elegible?

To join this study, you need to be an adult, 18 years old or older. There is no upper age limit, so people of all adult ages can take part.

This study is for both men and women, as gout can affect anyone.

Most importantly, you must have gout that is currently well-controlled, meaning you haven't had recent flare-ups and your doctor considers it to be in remission. The study will look more closely at your specific medical history to make sure it's suitable for you.

¿Podría este estudio ser adecuado para ti?

Responde estas preguntas rápidas para ver si puedes ser elegible. Esto es solo una guía: el equipo de investigación toma la decisión final.

  1. ¿Tienes 18 años o más?
  2. Do you have a diagnosis of gout?
  3. Is your gout currently well-controlled (in remission)?
  4. Are you currently taking medication for your gout?
Responde cada pregunta para ver tu resultado.

¿En qué consiste la participación?

If you join the study, you will be randomly put into one of two groups: one group will continue taking their current gout medication, and the other group will stop taking it. You won't get to choose which group you are in, as this helps make the study fair.

You will be followed for a total of two years (24 months). During this time, you'll have regular check-ups and assessments, likely at your local clinic, to see how your gout is doing. These check-ups will help the study team understand if your gout stays in remission, or if you have any flare-ups.

The study will focus on what happens in the last six months of the two-year period. You'll need to attend all scheduled appointments so that the researchers can get a full picture of your health and the effects of the treatment.

Riesgos y beneficios potenciales

Participating in this study might offer a potential benefit of understanding whether stopping your gout medication is appropriate, possibly reducing the number of medicines you take. However, there's also a potential risk that if you stop medication, your gout could worsen or you might experience flare-ups. If you continue medication, you might experience side effects, though these are known for these established drugs. All medical procedures carry some risks, and the study team will monitor you closely. You are always free to leave the study at any time, for any reason, without it affecting your usual medical care.

Ubicaciones (1)

Algunas ubicaciones de los sitios son aproximadas. Estamos mejorando esto — por favor verifique con el equipo de prueba antes de viajar.
  • —
    No verificado
    Países Bajos

Preguntas comunes

What kind of medication will I be taking?

You'll either continue taking your current gout medication (like allopurinol, benzbromarone, or febuxostat) or stop taking it, depending on which group you're in.

How long will the study last if I join?

The study will follow you for a total of two years (24 months).

Will I have to pay for anything if I'm in the study?

Usually, clinical trials cover the costs related to the study, such as specific medications or appointments. This should be confirmed by the study team.

¿Puedo abandonar el estudio en cualquier momento?

Yes, you are completely free to withdraw from the study at any point, and it won't affect your regular medical care.

What does 'gout in remission' mean?

It means your gout is currently well-controlled, and you haven't had any recent gout flare-ups or symptoms.

Cómo obtener más información

Siempre hable con su médico de cabecera o especialista antes de decidir participar en un estudio.

¿Interesado en participar?

Registra tu interés

Comparte tus detalles y el equipo de investigación para "GOut TrEatment STrategy (GO TEST) FINALE study, a multicentr…" se pondrá en contacto contigo si puedes ser elegible. Siempre habla con tu médico antes de aceptar participar.

Discusión

Discusión comunitaria

Impulsado por nuestro foro en community.patient.info. Por favor, sea respetuoso — esto no es un consejo médico.